These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7839414)

  • 1. Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis.
    Kuo PC; Dafoe DC; Alfrey EJ; Sibley RK; Scandling JD
    Transplantation; 1995 Jan; 59(1):135-8. PubMed ID: 7839414
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.
    Davis CL; Harrison KL; McVicar JP; Forg PJ; Bronner MP; Marsh CL
    Clin Transplant; 1995 Feb; 9(1):53-9. PubMed ID: 7742583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol.
    Birkeland SA; Andersen HK; Hamilton-Dutoit SJ
    Transplantation; 1999 May; 67(9):1209-14. PubMed ID: 10342310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation.
    Pirsch JD; Stratta RJ; Sollinger HW; Hafez GR; D'Alessandro AM; Kalayoglu M; Belzer FO
    Am J Med; 1989 Feb; 86(2):241-4. PubMed ID: 2536518
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.
    Darenkov IA; Marcarelli MA; Basadonna GP; Friedman AL; Lorber KM; Howe JG; Crouch J; Bia MJ; Kliger AS; Lorber MI
    Transplantation; 1997 Sep; 64(6):848-52. PubMed ID: 9326409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children.
    Green M; Kaufmann M; Wilson J; Reyes J
    Clin Infect Dis; 1997 Dec; 25(6):1344-9. PubMed ID: 9431375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.
    McDiarmid SV; Jordan S; Kim GS; Toyoda M; Goss JA; Vargas JH; Martín MG; Bahar R; Maxfield AL; Ament ME; Busuttil RW
    Transplantation; 1998 Dec; 66(12):1604-11. PubMed ID: 9884246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical detection of Epstein-Barr virus antigens in peripheral B lymphocytes after renal transplantation.
    Hornef MW; Wagner HJ; Fricke L; Bein G; Kirchner H
    Transplantation; 1995 Jan; 59(1):138-40. PubMed ID: 7839415
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-transplant lymphoproliferative disorders: a preventable complication of solid organ transplantation?
    Webber SA
    Pediatr Transplant; 1999 May; 3(2):95-9. PubMed ID: 10389129
    [No Abstract]   [Full Text] [Related]  

  • 10. Posttransplant Epstein-Barr virus infection is associated with elevated levels of CD19+ B lymphocytes.
    Morrissey PE; Lorber KM; Marcarelli M; Bia MJ; Kliger AS; Lorber MI
    Transplantation; 1995 Feb; 59(4):637-40. PubMed ID: 7533350
    [No Abstract]   [Full Text] [Related]  

  • 11. Opportunistic viral hepatitis in liver transplant recipients.
    Markin RS; Langnas AN; Donovan JP; Zetterman RK; Stratta RJ
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1520-1. PubMed ID: 1846476
    [No Abstract]   [Full Text] [Related]  

  • 12. [Infectious complications of lung and heart-lung transplantation].
    Nicod LP
    Rev Mal Respir; 1996 Nov; 13(5 Suppl):S41-7. PubMed ID: 9011910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
    J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus lymphoproliferation after bone marrow transplantation.
    Zutter MM; Martin PJ; Sale GE; Shulman HM; Fisher L; Thomas ED; Durnam DM
    Blood; 1988 Aug; 72(2):520-9. PubMed ID: 2840986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-10 and Epstein-Barr virus-induced posttransplant lymphoproliferative disorder.
    Birkeland SA; Bendtzen K
    Transplantation; 1996 May; 61(9):1425-6. PubMed ID: 8629314
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus--associated posttransplant lymphoproliferative disorder presenting as perirenal transplant lymphocele.
    Squiers EC; West JC; Leonard D; Latsha R; Miller J; Fetterolf N; Kelley SE; Tyler W
    Transplantation; 1993 Nov; 56(5):1278-9. PubMed ID: 8249138
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
    Humar A; Hébert D; Davies HD; Humar A; Stephens D; O'Doherty B; Allen U
    Transplantation; 2006 Mar; 81(6):856-61. PubMed ID: 16570008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of post-transplant lymphoproliferative disease and visceral leishmaniasis after kidney transplantation].
    Bacha MM; Abderrahim E; Ounissi M; Chaouech D; Cherif M; Turki S; Rajhi H; Znaidi N; Bahloul A; Trabelsi S; Khaled S; Ben Abdallah T; Ben Maïz H; Kheder A
    Nephrol Ther; 2011 Nov; 7(6):488-93. PubMed ID: 21376690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opportunistic infections in patients with inflammatory bowel disease undergoing immunosuppressive therapy].
    Bernal I; Domènech E; García-Planella E; Cabré E; Gassull MA
    Gastroenterol Hepatol; 2003 Jan; 26(1):19-22. PubMed ID: 12525323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.